Zhi Tong Cai Jing·2025-12-15 05:05Group 1 - The core viewpoint of the article highlights that Zhaoyan New Drug (06127) has seen a significant stock price increase of over 30% this month, with a current price of 22.14 HKD and a trading volume of 208 million HKD [1][1][1] Group 2 - The price of experimental monkeys has been rising rapidly, currently around 140,000 RMB each, driven by increased demand from preclinical CRO orders and limited supply capacity [1][1][1] - According to a report by Founder Securities, the supply of experimental monkeys is expected to remain tight, with some breeding facilities fully booked until Q1 2026, indicating potential for further price increases in the short term [1][1][1] Group 3 - Founder Securities estimates that if the average price of experimental monkeys reaches 84,900 RMB in 2024 and increases to 140,000 RMB by Q4 2025, Zhaoyan New Drug could see an estimated increase in fair value of approximately 220 million RMB in 2025, based on a known quantity of 23,200 monkeys [1][1][1]